[
  {
    "ts": "2026-02-19T14:34:00+00:00",
    "headline": "Top High-Yield Stocks to Double Up on Right Now",
    "summary": "If you are looking for high-yield stocks, these two turnaround stories offer yield and green shoots, suggesting better times are ahead.",
    "url": "https://www.fool.com/investing/2026/02/19/top-high-yield-stocks-to-double-up-on-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ad8e3682-badf-319c-b5cf-38156edfc875",
      "content": {
        "id": "ad8e3682-badf-319c-b5cf-38156edfc875",
        "contentType": "STORY",
        "title": "Top High-Yield Stocks to Double Up on Right Now",
        "description": "",
        "summary": "If you are looking for high-yield stocks, these two turnaround stories offer yield and green shoots, suggesting better times are ahead.",
        "pubDate": "2026-02-19T14:34:00Z",
        "displayTime": "2026-02-19T14:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2b0664059198ecfa5c1c5d5a5035e828",
          "originalWidth": 1200,
          "originalHeight": 762,
          "caption": "The words Dividend Yield in a notebook sitting on top of paper with a graph on it and a magnifying glass.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/At7i8MVNFpbL2aoo6QQRPQ--~B/aD03NjI7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2b0664059198ecfa5c1c5d5a5035e828.cf.webp",
              "width": 1200,
              "height": 762,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fFnfGr074k2_Oy3ucvdJSA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2b0664059198ecfa5c1c5d5a5035e828.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/19/top-high-yield-stocks-to-double-up-on-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-high-yield-stocks-double-143400663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "UPS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T14:53:04+00:00",
    "headline": "Where is Pfizer Inc. (PFE) Headed?",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Daiwa downgraded Pfizer Inc. (NYSE:PFE) to Neutral from Outperform and set a $27 price target. In another development, Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S. Food and Drug Administration accepted and granted Priority […]",
    "url": "https://finance.yahoo.com/news/where-pfizer-inc-pfe-headed-145304193.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6d2c1097-7f10-364d-ba87-8c2f46f2fcf0",
      "content": {
        "id": "6d2c1097-7f10-364d-ba87-8c2f46f2fcf0",
        "contentType": "STORY",
        "title": "Where is Pfizer Inc. (PFE) Headed?",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Daiwa downgraded Pfizer Inc. (NYSE:PFE) to Neutral from Outperform and set a $27 price target. In another development, Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S. Food and Drug Administration accepted and granted Priority […]",
        "pubDate": "2026-02-19T14:53:04Z",
        "displayTime": "2026-02-19T14:53:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/where-pfizer-inc-pfe-headed-145304193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-pfizer-inc-pfe-headed-145304193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T15:15:00+00:00",
    "headline": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
    "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
    "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
      "content": {
        "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
        "contentType": "STORY",
        "title": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
        "description": "",
        "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
        "pubDate": "2026-02-19T15:15:00Z",
        "displayTime": "2026-02-19T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T04:42:50+00:00",
    "headline": "2 Large-Cap Stocks on Our Watchlist and 1 We Brush Off",
    "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
    "url": "https://finance.yahoo.com/news/2-large-cap-stocks-watchlist-044250828.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c83da3db-fc82-3d06-af94-eb96da1a3ac3",
      "content": {
        "id": "c83da3db-fc82-3d06-af94-eb96da1a3ac3",
        "contentType": "STORY",
        "title": "2 Large-Cap Stocks on Our Watchlist and 1 We Brush Off",
        "description": "",
        "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
        "pubDate": "2026-02-19T04:42:50Z",
        "displayTime": "2026-02-19T04:42:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/c61640c8437706ea73eb8b245b33d1e6",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MO Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BpozzPBeo75HF2yEmWZNmw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/c61640c8437706ea73eb8b245b33d1e6.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/edtAiinyiVI0Y3VGstmnag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/c61640c8437706ea73eb8b245b33d1e6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-large-cap-stocks-watchlist-044250828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-large-cap-stocks-watchlist-044250828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MO"
            },
            {
              "symbol": "FISV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]